Quantbot Technologies LP Homology Medicines, Inc. Transaction History

Quantbot Technologies LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.6 - $4.17 $3,900 - $6,255	-1,500 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$3.64 - $7.78 $5,460 - $11,670	1,500 New	1,500 $5,000
Q3 2021 Nov 09, 2021	SELL	$6.01 - $8.71 $4,207 - $6,097	-700 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$6.02 - $9.64 $26,963 - $43,177	-4,479 Reduced 86.48%	700 $5,000
Q1 2021 May 14, 2021	BUY	$9.17 - $14.8 $47,491 - $76,649	5,179 New	5,179 $48,000

Q1 2020 May 13, 2020	SELL	$12.5 - $22.04 $46,650 - $82,253	-3,732 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$11.42 - $22.19 $42,619 - $82,813	3,732 New	3,732 $77,000

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.